ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,034.91
      -0.30%
      US Tech 100
      20,835.20
      -0.29%
      Dow Jones
      44,247.83
      -0.35%
      Brent Oil
      72.42
      0.67%
      Bitcoin
      97,296.83
      0.64%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Impact Biomedical Inc (IBO)

      7. Impact Biomedical Inc (IBO) News

      Impact Biomedical Inc

      Impact Biomedical Inc (IBO)

      Universal Ibogaine Inc
      2.37
      0.19
      (8.72%)
      Closed December 10 4:00PM
      Delayed by 15 minutes
      2.37
      0.00
      (0.00%)
      After Hours: 4:34PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      IBO News

      Official News Only

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 12 2024
      IBO (8.72%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 04 2024
      IBO (8.72%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 08 2024
      IBO (8.72%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      September 17 2024
      IBO (8.72%)

      IBO Discussion

      View Posts
      Disquisition Disquisition 2 months ago
      INCREDIBLE DUMPING
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      IBO...BOTTOM BOUNCER
      👍️0
      rizah rizah 2 years ago
      All resolutions were approved by the required majority of shareholders at Universal Ibogaine Inc.'s (IBO)annual general meeting ("AGM"), which was held on October 3, 2022 in Vancouver, British Columbia. The company is a life sciences company with a mission to provide medicalized ibogaine-centered addiction care.
      👍️0
      harry_brat harry_brat 2 years ago
      $IBO held on to its renowned capital market advisor

      UI recently announced that it has retained Mr. Shayne Nyquvest as their capital market advisor in a consulting role. Mr. Nyquvest has substantial capital markets experience, having assisted companies in the mining, cannabis, and other growing industries with strategic fund-raising initiatives for over 4 decades.
      👍️0
      Blue_Digital_Media Blue_Digital_Media 2 years ago
      Universal Ibogaine Inc. thanks to David for his contributions to the Company during his tenure as a Director.

      Watch now IBO for latest stock information.
      👍️0

      Your Recent History

      AMEX
      IBO
      Impact Biomedical
      Delayed Upgrade Clock